Navigation Links
NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
Date:3/26/2008

Researchers at the National Sun Yat-Sen University and Kaohsiung Medical University, Kaohsiung, Taiwan have revealed a new mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) attenuate tumor invasion and metastasis. The research, to be published in the April 2008 issue of Experimental Biology and Medicine, provides new insights for the understanding of the anti-cancer effects of NSAIDs.

NSAIDs have been used for the suppression of pain and inflammation in the clinic for many years. The main targets of these drugs are cyclooxygenases (COXs) which play critical roles in maintaining physiological homeostasis, mediating inflammatory reactions and promoting tumorigenesis. However, COX-independent effects are also important for the inhibition of cancer development by NSAIDs. Indeed, NSAIDs are considered as a novel class of effective chemopreventive drugs.

The research team, led by Wen-Chun Hung, Dean of College of Science, National Sun Yat-Sen University, and a recent doctorial graduate Mei-Ren Pan and two collaborators Hui-Chiu Chang and Lea-Yea Chuang of Kaohsiung Medical University found that NSAIDs up-regulated several anti-metastatic genes including secreted protein acidic and rich in cysteine (SPARC), thrombospindin-1 (TSP-1), TSP-3 and tissue inhibitors of metalloproteinase-2 (TIMP-2) in human lung cancer cells. Our functional assay suggested that increases of SPARC and other anti-metastatic genes were important for NSAIDs to inhibit tumor invasion and metastasis said Wen-Chun Hung. More importantly, we elucidated the underlying mechanism and demonstrated that up-regulation of SPARC in human lung cancer cells was mediated via inhibition of DNA methyltransferases (DNMTs) expression and promoter de-methylation. This is the first report to show that NSAIDs may inhibit the expression of DNMTs to reverse promoter methylation and to reactivate gene transcription.

The researchers say that hypermethylation of tumor suppresso
'/>"/>

Contact: Dr. Wen-Chung Hung
hung1228@ms10.hinet.net
886-752-52000 x5817
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
2. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
3. A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status
4. Overweight Hispanic children shown to have vascular inflammation
5. Anti-Inflammatory Drug Improves Glycemia, Lowers Inflammation in Obese, Young Adults
6. TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks
7. Cell-death receptor links cancer susceptibility and inflammation
8. iNOS expression may links chronic biliary inflammation to malignant transformation
9. Diabetes Linked to Blood Vessel Inflammation
10. Low-carb diet reduces inflammation and blood saturated fat in metabolic syndrome
11. Researchers develop powerful tool to study the genetics of inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...re/ -- The Generic,Pharmaceutical Association (GP...PhA President and CEO Kathleen Jaeger regarding th...merging Health Care Competition and Consumer Issue...ting this roundtable demonstrates the,growing mom...o safe and,affordable biogenerics sooner rather t...
(Date:11/21/2008)...swire/ -- New research at West Virginia Universit...cco product aimed at young adults is catching on. ...amel Snus - touted as a socially acceptable way to...vels of nicotine. , , "Camel Snus contains ...d Bruce Adkins of the state Division of Tobacco Pr...
(Date:11/21/2008)...rstCall/ -- Today, prescription drugs are the firs...ercent of patients suffering chronic conditions. ...condition account for 96 percent of all prescripti...ts. A proprietary new pharmacy model developed ov...SE: MHS ) significantly reduces critical gaps in...
(Date:11/21/2008)...de survey, 33 physicians credentialed to practice ... Hospital of Dallas were honored by Texas Monthly... , , Each year, the publishers of Texas Mo...urvey more than 38,000 medical professionals acros...l care, which doctor would you choose?" Key Profe...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
... at least 10 percent of genes in the human populat...ces they contain—a finding that alters current// t...cent similar in content and identity. This discov..., by Howard Hughes Medical Institute (HHMI) intern...
... deadly infections in humans and animals have show...om the inside out. Now, two new studies at the// J...d that, combined with specially-packaged anti-canc...pects for cancer eradication have dramatically imp...
...ot amputations is high in India, which has around ...s can be considerably reduced with proper foot car...ost diabetic patients, but special footwear is req...er foot deformities. The Diabetes Research Centre...
... that conducted a study on schizophrenic patients ...nd just as well to the older anti-psychotic drugs....a patients who needed a change in drugs as the tre...ive. They were then grouped and some were put on o...
Other Medicine News:Health News:Genetic Variation: We're More Different than We Thought 2Health News:Genetic Variation: We're More Different than We Thought 3Health News:Germ - Chemo Combo Fights Cancer 2Health News:Germ - Chemo Combo Fights Cancer 3Health News:Old Anti-psychotic Drugs Are Equally Good 2
(Date:11/20/2008)...FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI ) ann...hase 1B,clinical trial of their lead drug candida... at the Society for Integrative Oncology,s Fifth I... Company,s oral presentation was selected,as a to... of the Best of the,SIO Session on November 20, 2...
(Date:11/20/2008)...- Radius Health ("Radius") announced today that it...d institutional financing round, increasing total ... amount raised since the company,s inception to $1... participated in the financing, led by MPM Bio IV ...Wellcome Trust, HealthCare Ventures, Oxford Biosci...
(Date:11/20/2008)...- PAREXEL International Corporation (Nasdaq: PRX...rovider, today announced that it has opened an off... and clinical research capabilities. With the addi... throughout five important biopharmaceutical cente... Brazil, Chile, and Mexico. This expansion further...
(Date:11/19/2008)...osit Science Corporation,researcher, Dan Tinker, ...,Annual Conference in Washington, DC this week in... Boomers. The computerized brain plasticity-based...es that target auditory and,language systems. Th...rovements in cognition by improving speed and accu...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Work Time Predicts Sleep Time 375 1Work Time Predicts Sleep Time 375 2China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference 314 1QUANTEL Intends to Strengthen its Dermatology Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 372 1QUANTEL Intends to Strengthen its Dermatology Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH 372 2Lettuce leafy greens and E coli 370 1Lettuce leafy greens and E coli 370 2
...IRE)--Jul 2, 2007 - Metabasis Therapeutics,(NASDAQ...,discovery, development and commercialization of n...r diseases by targeting the liver,and liver pathwa...esident of finance and chief financial officer of ...in Emerging Growth Opportunities,Conference at the...
... 27, 2007 (PrimeNewswire via COMTEX News,Network) ..., the,leader in drug delivery for metabolic diseas...d today that it will be making three,poster presen...,Society of Pediatric Endocrinology in Helsinki, F...f=,"http://www.espe2007.org/">www.espe2007.org ). ...
Other Medicine Technology:Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth,Conference and Attend Pacific Growth Equities Conference 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3
Holder for QIAGEN 96-well plates, for use with QIAvac 96;
For monitoring vacuum pressure, suitable for use with all QIAvac manifolds;
DNA/RNA preparation in 8-multi channels
...llex Filter Units,Filter units with hydrophobic PT...Fluoropore membrane are ideal for the sterilizing ...ners, and for sterilizing or clarifying organic so...units are available with different outlet connecti...
Medicine Products: